当前位置: X-MOL首页最新SCI期刊查询及投稿分析系统 › BIOORGANIC & MEDICINAL CHEMISTRY LETTERS杂志
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
基本信息
期刊名称 BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
BIOORG MED CHEM LETT
期刊ISSN 0960-894X
期刊官方网站 http://www.elsevier.com/wps/find/journaldescription.cws_home/972/description#description
是否OA
出版商 Elsevier Ltd
出版周期 Semimonthly
始发年份 1991
年文章数 686
最新影响因子 2.7(2022)  scijournal影响因子  greensci影响因子
中科院SCI期刊分区
大类学科 小类学科 Top 综述
医学3区 CHEMISTRY, MEDICINAL 药物化学3区
CHEMISTRY, ORGANIC 有机化学3区
CiteScore
CiteScore排名 CiteScore SJR SNIP
学科 排名 百分位 2.50 0.696 0.780
Pharmacology, Toxicology and Pharmaceutics
Pharmaceutical Science
43 / 164 74%
Biochemistry, Genetics and Molecular Biology
Clinical Biochemistry
46 / 115 60%
Pharmacology, Toxicology and Pharmaceutics
Drug Discovery
50 / 146 66%
Chemistry
Organic Chemistry
57 / 177 68%
Biochemistry, Genetics and Molecular Biology
Molecular Medicine
87 / 165 47%
Biochemistry, Genetics and Molecular Biology
Biochemistry
186 / 407 54%
Biochemistry, Genetics and Molecular Biology
Molecular Biology
207 / 375 44%
补充信息
自引率 5.70%
H-index 121
SCI收录状况 Science Citation Index
Science Citation Index Expanded
官方审稿时间
网友分享审稿时间 数据统计中,敬请期待。
PubMed Central (PML) http://www.ncbi.nlm.nih.gov/nlmcatalog?term=0960-894X%5BISSN%5D
投稿指南
期刊投稿网址 http://ees.elsevier.com/bmcl/
收稿范围

Bioorganic & Medicinal Chemistry Letters publishes research communications of outstanding significance and timeliness on topics at the interface of chemistry and biology, together with invited concise review articles. The journal publishes reports of experimental results in medicinal chemistry, chemical biology and drug discovery and design, emphasizing new and emerging advances and concepts in these fields. The aim of the journal is to promote a better understanding at the molecular level of life processes, and living organisms, as well as the interaction of these with chemical agents. The journal continues to be a major forum for the first publication of new chemical entities prior to them entering clinical trials.

The Journal welcomes papers on:

  • the medicinal chemistry and associated biology (including target identification and validation) of established or new disease targets
  • the reporting of the discovery, design or optimization of potent new compounds or biological agents
  • the analysis and discussion of structure-activity relationships and pharmacological issues relevant to drug design and action using in vitro and in vivo models, including the use of computational techniques when closely linked to experimental data
  • the reporting of "first-in-class" new therapeutic compounds
  • the chemical biology or bioorganic/bioinorganic chemistry that significantly advances knowledge of a biological mechanism
  • methodological advances that are chemistry-based and which significantly impact on medicine or biology
  • the preparation and examination of biotherapeutics for the treatment of pathophysiological disease states
  • the development of materials for specific therapeutic targeting



Manuscripts on phytochemistry, theoretical molecular dynamics and exclusively computational papers are out of scope. All manuscripts will be rigorously peer-reviewed by independent experts following an initial assessment by the Editors. Please note that BMCL is not suitable for straightforward reports of incremental advances. Above all the presentation of a rational basis and a sound underlying hypothesis for the work is of particular importance, whatever its exact field.


收录体裁
投稿指南 https://www.elsevier.com/journals/bioorganic-and-medicinal-chemistry-letters/0960-894x/guide-for-authors
投稿模板
参考文献格式 https://www.elsevier.com/journals/bioorganic-and-medicinal-chemistry-letters/0960-894x/guide-for-authors
编辑信息

                                
我要分享  (欢迎您来完善期刊的资料,分享您的实际投稿经验)
研究领域:
投稿录用情况: 审稿时间:  个月返回审稿结果
本次投稿点评:
提交
down
wechat
bug